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Leptomeningeal Seeding in Cho-
roidal Melanoma after Enucleation 
Surgery
Dear Editor,
Choroidal melanoma is the most common primary intra-
ocular malignancy and has a high potential for site-specific 
metastasis. It is known to metastasize to the liver and lungs 
through hematogenous spread. However, brain metastasis 
is rare without a prior liver metastasis. In general, the pres-
ence of metastasis determines a patient’s prognosis and 
survival. Borkar et al. [1] reported a case of choroidal mel-
anoma with an isolated brain metastasis that developed 
following enucleation. Similarly, in this report, we present 
a rare case of choroidal melanoma with extensive leptome-
ningeal metastasis that occurred a year following intensity 
modulated radiation therapy (IMRT) and enucleation with 
hydroxyapatite implantation.
A 49-year-old female visited the retina specialty clinic in 
September 2015 for continuous visual deterioration and 
metamorphopsia over the previous 2 months. She had re-
ceived intravitreal anti-vascular endothelial growth factor 
for exudative retinal detachment (RD) at another hospital. 
At initial examination, corrected visual acuity was 10 / 200 
in the left eye with exudative RD. Orbital sonography and 
magnetic resonance imaging revealed an inferior choroidal 
pigmented mass of 14.73-mm diameter and 7.14-mm 
height. No other systemic metastases were found.
Based on the Collaborative Ocular Melanoma Study, the 
tumor was a medium-sized choroidal melanoma, and there 
was no difference in the 5-year survival following treat-
ment with either iodine-125 brachytherapy or enucleation 
[2]. The patient refused enucleation and was referred to the 
radiology department for IMRT. In October 2015, she re-
ceived a total dose of 60 Gy over 10 days, and her vision 
subsequently deteriorated to no light perception. 
After radiation therapy, exudative RD was continuously 
observed, and the vision continued to be no light percep-
tion. It was previously reported that vitrectomy can be 
safely performed in eyes with previously irradiated uveal 
melanoma in order to prevent a patient from having to un-
dergo enucleation. Several studies have shown that vitrec-
tomy does not increase the risk for intraocular, orbital, or 
systemic dissemination of the tumor [3]. Therefore, the pa-
tient in the present case underwent a vitrectomy with oil 
injection on June 2016 to prevent enucleation although the 
visual prognosis was not favorable.  
Despite close follow up for 6 months, she developed a 
recurred melanoma with abrupt rupture through the sclera 
and extraocular extension into the subconjunctival space 
(Fig. 1A, 1B). In December 2017, an emergent enucleation 
was performed. After tumor free margins were confirmed 
by multiple frozen sections of the conjunctiva, tenon’s lay-
er and superior rectus muscles, an 18-mm hydroxyapatite 
implant was placed. Histopathology showed an epithelioid 
cell type choroidal melanoma with a tumor-free margin 
around the optic nerve, despite tumor extension through 
the optic nerve (Fig. 1C, 1D). At the time of enucleation, no 
systemic or local metastasis was observed. In January 
2019, the patient was admitted to the emergency depart-
ment with vomiting and headache. Magnetic resonance 
imaging showed extensive leptomeningeal seeding in the 
brain without metastasis to the liver or lungs (Fig. 1E, 1F). 
The patient agreed to undergo palliative treatment without 
chemotherapy at a terminal care hospital, and she died 
comfortably 3 months later.
A choroidal melanoma with extraocular extension has a 
3-year survival rate of 37% and a 5-year survival rate of 
27% [4]. Tumor size, location, cell type, extraocular exten-
sion, and age at initial presentation determine the progno-
sis. The poor prognostic indicators in the present case were 
tumor size >1.0 cm3, presence of epithelioid cells, and ex-
traocular extension. 
The high dose radiation of IMRT could have caused 
scleral extension of the tumor by weakening the scleral tis-
sue [5]. We assume that combined vitrectomy and IMRT 
could have triggered extraocular extension. Additionally, 
we consider microscopic extension of tumor into the orbit 
that might have been missed during enucleation despite 
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ensuring tumor free margins on frozen sections. The hy-
droxyapatite implant might have impaired early detection 
of the recurrence and prevented quick tumor growth. A 
subtotal exenteration without implant might have improved 
the prognosis either by facilitating complete microscopic 
excision or by not inhibiting early detection of the recur-
rence. Finally, adjuvant orbital radiation following enucle-
ation should have been considered for undetected micro-
scopic metastasis.
To conclude, we present a rare case of choroidal melano-
ma with rapid and extensive leptomeningeal metastasis 
following IMRT and enucleation. Thus, in patients with 
high metastatic potential, we recommend early and aggres-
sive surgical intervention combined with adjunct therapies 
and regular follow up with brain imaging to detect early 
spread.  
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Fig. 1. (A,B) Slit-lamp photograph of recurred choroidal mel-
anoma with abrupt rupture through the sclera and extraocular 
extension into the superior subconjunctival space. (C) Gross pho-
tograph of specimen after enucleation. The length between two 
bold lines is 1 cm. (D) Histologic findings of epitheloid cell type 
choroidal melanoma (hematoxylin and eosin stain, ×200). (E,F) 
Magnetic resonance imaging findings of extensive leptomeninge-
al seeding in the brain.  
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